Skip to content
Clinical Trials – home

Vulvovaginal pruritus Diagnostics

1 / 1 trials open to patients1 country

In short

Vulvovaginal pruritus, or itching in the area around the vagina and vulva, affects many women at some point in their lives. This uncomfortable symptom can have many different causes, from simple irritation to infections and skin conditions. Understanding when to seek medical attention and what tests might be needed can help you get the right diagnosis and relief from this bothersome problem.

Key points

  • Vulvovaginal itching affects 5-10% of women and is one of the most common reasons for seeking gynecologic care, yet many women delay seeking help due to embarrassment.
  • The diagnostic process begins with a thorough discussion of symptoms, medical history, and exposure to potential irritants—this conversation is just as important as the physical examination.
  • Up to one-third of vulvovaginitis cases are caused by irritants or allergic reactions rather than infections, making it crucial to review all products that come into contact with the vulvar area.
  • A simple microscopic examination of vaginal discharge using a wet preparation can quickly diagnose many yeast infections, while pH testing helps distinguish between different types of infections.
  • Women before puberty and after menopause are more vulnerable to vulvar conditions because lower estrogen levels lead to thinner, dryer tissues and changes in the natural vaginal environment.
  • Finding Candida (yeast) in vaginal cultures without symptoms is normal for 10-20% of women and doesn't require treatment—diagnosis should always be based on both symptoms and test results.
  • Persistent itching that doesn't respond to treatment should be thoroughly investigated with additional testing, including possibly a biopsy, to rule out less common but serious conditions.
  • The characteristics of vaginal discharge—including color, consistency, and odor—provide important diagnostic clues, but microscopic examination is needed for accurate diagnosis.

Introduction: Who Should Undergo Diagnostics and When to Seek Medical Help

Vulvovaginal pruritus is one of the most common reasons women seek gynecologic care. Studies suggest that between five and ten percent of women experience itching affecting their female genitalia specifically. In a survey of women in Boston, Massachusetts, about six and a half percent reported experiencing vulvar itch or burning, which is similar to rates reported in Germany, where the condition affects five to ten percent of the general population.

Vulvovaginal symptoms are so frequent that some general practitioners in the United Kingdom report seeing more than five patients per month with vulvar symptoms, with itching being the most common complaint. In clinics specializing in vulvar conditions, itch was found to be the most frequent symptom, occurring in seventy percent of patients presenting for care.

While occasional mild itching may not require immediate medical attention, certain situations call for a visit to your healthcare provider. You should seek medical help if you develop vaginal discomfort, particularly if you have a particularly unpleasant vaginal odor, discharge, or itching that doesn't go away. If you've never had a vaginal infection before, it's especially important to see your healthcare provider rather than trying to treat it yourself.

Persistent or recurrent pain, irritation, burning, and itching are not normal and require further evaluation. These symptoms shouldn't be ignored or assumed to be minor, as they can significantly impact your quality of life. Research has shown that vulvovaginal pruritus can have a profound effect on daily activities, sexual relationships, sleep quality, and self-esteem.

Anyone with a vulva can experience vulvovaginal pruritus, but certain groups are more vulnerable. The condition is more common in children and people who've gone through menopause. This is because estrogen levels are lower before puberty and after menopause, which leads to thinner, dryer vulvar tissues (the external female genital area). This thinning increases the risk of injury and inflammation in this delicate area.

Diagnostic Methods: Classic Tests to Identify the Cause

When you visit your healthcare provider for vulvovaginal itching, they will begin with a thorough evaluation to identify the underlying cause. The diagnostic process typically starts with a detailed conversation about your symptoms and medical history. Your provider will ask about your symptoms, when they started, what makes them better or worse, and whether you have any history of allergies, eczema, or related conditions.

Your healthcare provider will also inquire about your personal hygiene habits and any products your vulva has been exposed to. This is important because many cases of vulvovaginal itching result from irritant contact dermatitis, which means inflammation caused by contact with substances that irritate the skin. Common irritants include scented soaps, bubble baths, perfumed toilet paper, certain laundry detergents, fabric softeners, vaginal sprays, douches, and even some types of pads or tampons.

Physical Examination

After discussing your medical history, your healthcare provider will perform a physical exam and a complete pelvic exam (an examination of the female reproductive organs). During this examination, they will carefully look for skin changes that may indicate various conditions. These changes can include redness, swelling, blisters, lesions, small cracks in the skin, thick whitish patches, or areas where the skin appears scaly.

The provider will perform a detailed, systematic examination of the vulvar area. They will assess the vulvar architecture (the structure and appearance of the external genitals) and examine the epithelium (the outer layer of skin and mucous membranes) for any abnormalities. If inflammation affects both the vulva and the vagina, this is called vulvovaginitis, and your provider may use terms like vulvitis, vaginitis, and vulvovaginitis interchangeably.

Vaginal Discharge Analysis

One of the most important diagnostic tools is the examination of vaginal discharge and vaginal fluid. Your healthcare provider will check your vaginal fluid for signs of infection. This typically involves taking a small sample of discharge and examining it under a microscope.

For yeast infections, the diagnosis can be made when a wet preparation (a sample mixed with saline or a solution called ten percent KOH) of vaginal discharge shows budding yeasts, thread-like structures called hyphae, or branching structures called pseudohyphae. The KOH solution is particularly helpful because it disrupts other cellular material that might hide the yeast structures, making them easier to see. Women with symptoms or signs of a yeast infection who have a positive wet mount should be treated.

For those with negative wet mounts but existing signs or symptoms, vaginal cultures for Candida (the fungus that causes yeast infections) should be considered. However, it's important to note that finding Candida in a culture when there are no symptoms is not an indication for treatment, because approximately ten to twenty percent of women harbor Candida species and other yeasts in the vagina naturally.

pH Testing

Testing the pH (a measure of acidity or alkalinity) of the vagina can help distinguish between different types of infections. Normally, in reproductive-aged women, the vaginal pH ranges from 3.5 to 4.5, which is slightly acidic. Candida vaginitis, or yeast infection, is associated with a normal vaginal pH of less than 4.5. In contrast, bacterial vaginosis and some other infections may cause the pH to become more alkaline, rising above 4.5.

This pH difference occurs because in healthy reproductive-aged women, beneficial bacteria called Lactobacillus species are the predominant bacteria in the vagina. High levels of a substance called glycogen in the vaginal cells, which is promoted by the hormone estrogen, encourage Lactobacillus growth. These bacteria keep the pH in the normal range, which prevents overgrowth of harmful bacteria. In women before puberty and after menopause, lack of estrogen leads to lower glycogen levels, thinner vaginal tissues, and a higher pH above 4.5.

Laboratory Tests

Depending on what your healthcare provider finds during the initial examination, they may order additional laboratory tests. These can include urine tests to check for urinary tract infections, blood tests to evaluate overall health or check for conditions like diabetes, and tests for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, trichomoniasis, or genital herpes.

A Pap smear (a test that collects cells from the cervix to check for abnormalities) may also be performed as part of routine screening or if there are concerns about cervical health. In some cases where a sexually transmitted infection is suspected, specific STI tests will be ordered. For example, trichomoniasis, which is usually sexually transmitted and causes a type of vaginitis, can be detected through microscopic examination or other testing methods.

Vulvar Biopsy

In certain situations, particularly when there are visible skin changes that don't respond to initial treatment or when there's concern about precancerous or cancerous changes, your healthcare provider may recommend a vulvar biopsy. This procedure involves taking a small sample of vulvar tissue for examination under a microscope. A biopsy can help diagnose skin conditions like lichen sclerosus (an inflammatory disorder that causes white, crinkly patches) or lichen planus (an inflammatory condition affecting skin and mucous membranes).

It's particularly important to consider a biopsy in cases of persistent itching that doesn't respond to treatment, especially in refractory cases. In these situations, an invasive or pre-invasive lesion such as vulvar intraepithelial neoplasia (VIN), which is a precancerous skin condition, should be kept in mind. Although vulvar cancer is rare, persistent itching can sometimes be a sign, and a biopsy is the definitive way to rule out or confirm such conditions.

Cultures and Specialized Testing

When initial tests don't provide clear answers, your provider may order cultures to grow and identify specific bacteria, yeasts, or other organisms. Yeast culture can identify a broad group of pathogenic yeasts and remains the reference standard for diagnosis. This is particularly important when dealing with complicated or recurrent infections.

Some providers use more advanced testing methods, though it's worth noting that the majority of PCR tests (molecular tests that detect genetic material) for yeast are not cleared by the FDA, and providers who use these tests should be familiar with how well the specific test performs. However, these specialized tests can be helpful in difficult-to-diagnose cases.

Differentiating Between Common Causes

The characteristics of vaginal discharge can provide important clues about the cause of vulvovaginal itching. With bacterial vaginosis, you might develop a grayish-white discharge with a foul smell, often described as fishy, which might be more obvious after sex. Yeast infections typically produce a thick, white discharge that resembles cottage cheese, accompanied by intense itching. Trichomoniasis, a parasitic infection, can cause a greenish-yellow, sometimes frothy discharge.

However, these visual characteristics alone are not always reliable for diagnosis, which is why microscopic examination and other tests are important. The most common causes of vulvovaginal itching and discharge vary depending on hormonal status. In reproductive-aged women, the most common causes are bacterial vaginosis, candidal vulvovaginitis (yeast infection), and trichomonal vaginitis. In postmenopausal women, genitourinary syndrome of menopause (formerly called atrophic vaginitis) is a common cause, which results from the decline in estrogen after menopause.

Diagnostics for Clinical Trial Qualification

While the sources provided do not contain specific information about diagnostic criteria or testing methods used as standard requirements for enrolling patients in clinical trials for vulvovaginal pruritus, it's worth noting that clinical trials generally require thorough documentation of symptoms and confirmed diagnosis of the underlying condition being studied. Participants in such trials would typically undergo the same diagnostic procedures described above to establish baseline measurements and ensure they meet the study's inclusion criteria.

Did you know?

  1. An estimated 75% of women will have at least one episode of vulvovaginal candidiasis (yeast infection) in their lifetime, and 40-45% will experience two or more episodes.
  2. The vaginal environment changes dramatically throughout a woman's life—prepubertal and postmenopausal patients have a vaginal pH above 4.5 with sparse numbers of protective Lactobacillus bacteria, while reproductive-aged women maintain a more acidic pH of 3.5 to 4.5.
  3. Chronic vulvar itching can lead to a condition called lichen simplex chronicus, where constant scratching causes the skin to become thick and leathery, creating a cycle where the thickened skin itches even more.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Vulvovaginal pruritus

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nomegestrol Acetate
  • Sponsor:Aarhus University Hospital
See all 1 trials →filters applied: condition = Vulvovaginal pruritus

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).